Helena has a broad experience in pharmacovigilance, research and development with clinical trials and non-interventional studies with about 26 years of experience from industry and 8 years of experience from competent authority. Her most recent position is as Pharmacovigilance Inspector as function responsible for pharmacovigilance inspections at the Swedish Medical Products Agency (MPA) and has been Sweden's representative in the pharmacovigilance inspectors working group at the European Medicines Agency, EMA. Helena has carried out several inspections where the Swedish MPA is the responsible authority at EU level and also several inspections in collaboration with other authorities. Helena also has previous experience as a Senior Clinical Trial Manager in the pharmaceutical industry.
We are very pleased that Helena Tidlund will contribute to PharmaRelations success with her expertise, knowledge and networks in the field of pharmacovigilance.” says Fredrik Anjou, CEO of PharmaRelations.
For more information please contact
Ulrika Lundahl, firstname.lastname@example.org, tel. 070-165 22 54 or
Helena Tidlund, email@example.com, tel.070-165 22 51